NRG GY018: Pembrolizumab in Advanced Endometrial Cancer Last updated on May 1, 2024 Previous MITO-7: Weekly chemotherapy in ovarian cancer Next RUBY - Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer
